Apellis Pharmaceuticals, Inc.【APLS】 営業利益の推移

機能の使い方
(単位:千ドル) 営業利益 前年比(%)
4Q25 -51,142 +95.5%
3Q25 223,183 -572.0%
2Q25 -33,286 +13.1%
1Q25 -83,328 +34.2%
4Q24 -26,164 -69.0%
3Q24 -47,280 -65.5%
2Q24 -29,443 -75.6%
1Q24 -62,090 -64.5%
4Q23 -84,518 -48.5%
3Q23 -137,080 -10.4%
2Q23 -120,441 -19.0%
1Q23 -175,083 +35.7%
4Q22 -164,053 +83.5%
3Q22 -152,938 +19.5%
2Q22 -148,624 -23.5%
1Q22 -128,998 +3.5%
4Q21 -89,404 -168.7%
3Q21 -127,995 -1.2%
2Q21 -194,287 +68.2%
1Q21 -124,591 +26.1%
4Q20 130,120 -222.8%
3Q20 -129,552 +85.2%
2Q20 -115,508 +82.0%
1Q20 -98,786 +103.1%
4Q19 -105,941 +184.8%
3Q19 -69,948 +95.4%
2Q19 -63,477 +89.6%
1Q19 -48,651 +126.9%
4Q18 -37,197 +111.7%
3Q18 -35,805 +208.9%
2Q18 -33,486 -
1Q18 -21,439 -
4Q17 -17,569 -
3Q17 -11,590 -